Making a Killer: Selecting the Optimal Natural Killer Cells for Improved Immunotherapies

Over the past 20 years natural killer (NK) cell-based immunotherapies have emerged as a safe and effective treatment option for patients with relapsed or refractory leukemia. Unlike T cell-based therapies, NK cells harbor an innate capacity to eliminate malignant cells without prior sensitization an...

Descripción completa

Detalles Bibliográficos
Autores principales: Barnes, Samantha A., Trew, Isabella, de Jong, Emma, Foley, Bree
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8578927/
https://www.ncbi.nlm.nih.gov/pubmed/34777383
http://dx.doi.org/10.3389/fimmu.2021.765705

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8578927/
https://www.ncbi.nlm.nih.gov/pubmed/34777383
http://dx.doi.org/10.3389/fimmu.2021.765705

Ejemplares similares